CG Oncology (CGON) operating margin

Operating margin · fiscal 2025
-4722.1%

CG Oncology (CGON) had an operating margin of -4722.1% in fiscal 2025 (the year ended December 31, 2025). That is 5345.1 percentage points higher than the -10067.3% of fiscal 2024. Figures as of 17 Nov 2026, 21:17 UTC, from Yahoo Finance.

Key facts

Operating margin, fiscal 2025
-4722.1%
Change on fiscal 2024
+5345.1 pts
Highest on record
-4722.1%fiscal 2025
Lowest on record
-27180.9%fiscal 2023
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Figures, not advice.

CG Oncology operating margin, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was -4722.1% in fiscal 2025 and the lowest -27180.9% in fiscal 2023. The fiscal 2025 figure is higher than in every one of the 3 earlier fiscal years on record, whose median is -18453.4%.

Gross margin was -15.0% in fiscal 2025. Net margin was -3985.0% in fiscal 2025.

History · 4 fiscal years

Operating margin by fiscal year

  • Operating margin
  • Gross margin
  • Net margin

CG Oncology operating margin, year by year

CG Oncology (CGON) operating margin by fiscal year
Fiscal yearOperating marginChangeYear endedGross marginNet margin
2025-4722.1% 5345.1 pts up-15.0%-3985.0%
2024-10067.3% 17113.6 pts up100.0%-7729.5%
2023-27180.9% 8727.5 pts down100.0%-23827.0%
2022-18453.4%——-18556.5%

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

Operating margin at health care companies of similar size

Operating margin of CG Oncology and comparable companies
CompanyOperating marginFiscal year
Arrowhead Pharmaceuticals ARWR-156.9%2026
MSA Safety MSA20.9%2025
CG Oncology CGON-4722.1%2025
Lantheus Holdings LNTH20.5%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on CGON

CG Oncology, figure by figure

CG Oncology (CGON) overview: price, valuation and scorecardAll health care companies by market value

CG Oncology operating margin: questions and answers

What is CG Oncology's operating margin?

CG Oncology (CGON) had an operating margin of -4722.1% in fiscal 2025 (the year ended December 31, 2025). That is 5345.1 percentage points higher than the -10067.3% of fiscal 2024.

Is CG Oncology's operating margin high or low compared with its own history?

The fiscal 2025 figure is higher than in every one of the 3 earlier fiscal years on record, whose median is -18453.4%.

What are the highest and lowest operating margin figures on record for CG Oncology?

Across the 4 fiscal years on record (2022–2025), the highest was -4722.1% in fiscal 2025 and the lowest -27180.9% in fiscal 2023.

What are CG Oncology's gross and net margins?

Gross margin was -15.0% in fiscal 2025. Net margin was -3985.0% in fiscal 2025.

How is CG Oncology's operating margin calculated?

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “CG Oncology (CGON) operating margin”, data as of 17 November 2026. https://funkfolio.com/stock/CGON/operating-margin

Underlying data: Yahoo Finance.